Skip to menu Skip to content Skip to footer

2017

Conference Publication

RCT of Exenatide for Clozapine-associated obesity

Siskind, Dan, Russell, Anthony, Gamble, Clare, Winckel, Karl, Hollingworth, Sam and Kisely, Steve (2017). RCT of Exenatide for Clozapine-associated obesity. 16th International Congress on Schizophrenia Research (ICOSR), San Diego, CA, United States, 24-28 March 2017. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/schbul/sbx023.046

RCT of Exenatide for Clozapine-associated obesity

2017

Journal Article

Lithium augmentation as an alternative to maintenance electroconvulsive therapy for recurrent major depressive disorder in older adults

Wysoczanski, Daniel, Cherry, Scott, Spivak, Valeria, Lie, David and Siskind, Dan (2017). Lithium augmentation as an alternative to maintenance electroconvulsive therapy for recurrent major depressive disorder in older adults. Australasian Psychiatry, 25 (1), 84-84. doi: 10.1177/1039856216658825

Lithium augmentation as an alternative to maintenance electroconvulsive therapy for recurrent major depressive disorder in older adults

2017

Journal Article

Mania associated with self-prescribed acetyl-L-carnitine in a man with bipolar I disorder

Goodison, Geraldine, Overeem, Kathie, de Monte, Veronica and Siskind, Dan (2017). Mania associated with self-prescribed acetyl-L-carnitine in a man with bipolar I disorder. Australasian Psychiatry, 25 (1), 13-14. doi: 10.1177/1039856216658831

Mania associated with self-prescribed acetyl-L-carnitine in a man with bipolar I disorder

2017

Journal Article

Motivational aftercare planning to better care: applying the principles of advanced directives and motivational interviewing to discharge planning for people with mental illness

Kisely, Steve, Wyder, Marianne, Dietrich, Josie, Robinson, Gail, Siskind, Dan and Crompton, David (2017). Motivational aftercare planning to better care: applying the principles of advanced directives and motivational interviewing to discharge planning for people with mental illness. International Journal of Mental Health Nursing, 26 (1), 41-48. doi: 10.1111/inm.12261

Motivational aftercare planning to better care: applying the principles of advanced directives and motivational interviewing to discharge planning for people with mental illness

2017

Journal Article

The prevalence of depression and anxiety disorders in indigenous people of the Americas: a systematic review and meta-analysis

Kisely, Steve, Alichniewicz, Karolina Katarzyna, Black, Emma B., Siskind, Dan, Spurling, Geoffrey and Toombs, Maree (2017). The prevalence of depression and anxiety disorders in indigenous people of the Americas: a systematic review and meta-analysis. Journal of Psychiatric Research, 84, 137-152. doi: 10.1016/j.jpsychires.2016.09.032

The prevalence of depression and anxiety disorders in indigenous people of the Americas: a systematic review and meta-analysis

2017

Conference Publication

Rehabilitation for Australians living with complex psychoses: epidemiological data on how the current gap between evidence and implementation may be bridged

Harvey, C., Farhall, J., Parsons, S., Lewis, J., Brophy, L., Moeller-Saxone, K., Grigg, M. and Siskind, D. (2017). Rehabilitation for Australians living with complex psychoses: epidemiological data on how the current gap between evidence and implementation may be bridged. RANZCP 2017 Congress, Adelaide, Australia, 30 April - 4 May 2017. London, United Kingdom: Sage Publications.

Rehabilitation for Australians living with complex psychoses: epidemiological data on how the current gap between evidence and implementation may be bridged

2017

Conference Publication

Treatment of clozapine-associated obesity and diabetes with exenatide (Codex) in adults with schizophrenia

Siskind, D. (2017). Treatment of clozapine-associated obesity and diabetes with exenatide (Codex) in adults with schizophrenia. RANZCP 2017 Congress, Adelaide, Australia, 30 April - 4 May 2017. London, United Kingdom: Sage Publications.

Treatment of clozapine-associated obesity and diabetes with exenatide (Codex) in adults with schizophrenia

2017

Conference Publication

How to disseminate your research findings?

Siskind, D. (2017). How to disseminate your research findings?. RANZCP 2017 Congress, Adelaide, Australia, 30 April - 4 May 2017. London, United Kingdom: Sage Publications.

How to disseminate your research findings?

2017

Conference Publication

Schizophrenia and physical health - a whole body experience

Hahn, L., Kisely, S., Suetani, S., Lappin, Julia and Siskind, D. (2017). Schizophrenia and physical health - a whole body experience. LONDON: SAGE PUBLICATIONS LTD. doi: 10.1177/0004867417702054

Schizophrenia and physical health - a whole body experience

2017

Conference Publication

Are collaborations the key to successful public sector research?

Galletly, C., Sujeeve, S., Liu, D., Schubert, O. and Siskind, D. (2017). Are collaborations the key to successful public sector research?. RANZCP 2017 Congress, Adelaide, Australia, 30 April - 4 May 2017. London, United Kingdom: Sage Publications.

Are collaborations the key to successful public sector research?

2017

Conference Publication

Clozapine and ECT for treatment-refractory schizophrenia

Siskind, D. (2017). Clozapine and ECT for treatment-refractory schizophrenia. RANZCP 2017 Congress, Adelaide, Australia, 30 April - 4 May 2017. London, United Kingdom: Sage Publications.

Clozapine and ECT for treatment-refractory schizophrenia

2017

Conference Publication

Evaluating Effects of a Physical Activity Intervention Implemented At a Residential Mental Health Rehabilitation Unit

Korman, N., Siskind, D., Shah, S., Dark, F., Kendall, K. and Nadareishvili, K. (2017). Evaluating Effects of a Physical Activity Intervention Implemented At a Residential Mental Health Rehabilitation Unit. RANZCP 2017 Congress, Adelaide, Australia, 30 April - 4 May 2017. London, United Kingdom: Sage Publications.

Evaluating Effects of a Physical Activity Intervention Implemented At a Residential Mental Health Rehabilitation Unit

2017

Conference Publication

Integrating psychiatric rehabilitation into clinical practice

Killaspy, H., Harvey, C., Dark, F. and Siskind, D. (2017). Integrating psychiatric rehabilitation into clinical practice. RANZCP 2017 Congress, Adelaide, Australia, 30 April - 4 May 2017. London, United Kingdom: Sage Publications.

Integrating psychiatric rehabilitation into clinical practice

2017

Conference Publication

Collaborations with Junior Colleagues for Building Research Capacity in the Public Sector

Siskind, D., Kisely, S. and Parker, S. (2017). Collaborations with Junior Colleagues for Building Research Capacity in the Public Sector. LONDON: SAGE PUBLICATIONS LTD. doi: 10.1177/0004867417702054

Collaborations with Junior Colleagues for Building Research Capacity in the Public Sector

2017

Conference Publication

Biopsychosocial and more: treating difficult to treat psychotic disorder

Siskind, D., Dark, F., Korman, N., Parker, S. and Clark, S. (2017). Biopsychosocial and more: treating difficult to treat psychotic disorder. RANZCP 2017 Congress, Adelaide, Australia, 30 April - 4 May 2017. London, United Kingdom: Sage Publications.

Biopsychosocial and more: treating difficult to treat psychotic disorder

2017

Conference Publication

Dopamine-Dysregulation Syndrome: a Systematic Review of Adiction to Dopamine and its Neuropsychiatric Consequences

Warren, N., Nyguen, D., O'Gorman, C., Lehn, A. and Siskind, D. (2017). Dopamine-Dysregulation Syndrome: a Systematic Review of Adiction to Dopamine and its Neuropsychiatric Consequences. RANZCP 2017 Congress, Adelaide, Australia, 30 April – 4 May 2017. LONDON: Sage.

Dopamine-Dysregulation Syndrome: a Systematic Review of Adiction to Dopamine and its Neuropsychiatric Consequences

2016

Journal Article

Fever, confusion, acute kidney injury: is this atypical neuroleptic malignant syndrome following polypharmacy with clozapine and risperidone?

Cherry, Scott, Siskind, Dan, Spivak, Valeria, Wysoczanski, Daniel and Halangoda, Priyangika (2016). Fever, confusion, acute kidney injury: is this atypical neuroleptic malignant syndrome following polypharmacy with clozapine and risperidone?. Australasian Psychiatry, 24 (6), 602-603. doi: 10.1177/1039856216649768

Fever, confusion, acute kidney injury: is this atypical neuroleptic malignant syndrome following polypharmacy with clozapine and risperidone?

2016

Journal Article

Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis

Siskind, Dan, McCartney, Lara, Goldschlager, Romi and Kisely, Steve (2016). Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis. British Journal of Psychiatry, 209 (5), 385-392. doi: 10.1192/bjp.bp.115.177261

Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis

2016

Journal Article

An evidence-based scale for the antecedents of depressive symptoms in Australian adults

Liu, Xin, Furuya-Kanamori, Luis, Siskind, Dan, Crompton, David, Williams, Gail M., Kostner, Karam, Vitetta, Luis and Doi, Suhail A. (2016). An evidence-based scale for the antecedents of depressive symptoms in Australian adults. Australasian Psychiatry, 24 (5), 466-469. doi: 10.1177/1039856216629842

An evidence-based scale for the antecedents of depressive symptoms in Australian adults

2016

Journal Article

N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms

Rossell, Susan L., Francis, Paul S., Galletly, Cherrie, Harris, Anthony, Siskind, Dan, Berk, Michael, Bozaoglu, Kiymet, Dark, Frances, Dean, Olivia, Liu, Dennis, Meyer, Denny, Neill, Erica, Phillipou, Andrea, Sarris, Jerome and Castle, David J. (2016). N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms. BMC Psychiatry, 16 (1) 320, 320. doi: 10.1186/s12888-016-1030-3

N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms